Birchview Capital as of March 31, 2018
Portfolio Holdings for Birchview Capital
Birchview Capital holds 49 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 41.7 | $63M | 709k | 89.21 | |
Accelr8 Technology | 32.9 | $50M | 2.2M | 22.85 | |
Neurocrine Biosciences (NBIX) | 2.9 | $4.3M | 52k | 82.94 | |
Vermillion | 2.1 | $3.2M | 2.4M | 1.36 | |
Oxford Immunotec Global | 1.4 | $2.2M | 177k | 12.45 | |
EQT Corporation (EQT) | 1.3 | $2.0M | 42k | 47.52 | |
Contrafect | 1.2 | $1.9M | 1.1M | 1.63 | |
Array BioPharma | 1.2 | $1.8M | 112k | 16.32 | |
Quidel Corporation | 1.2 | $1.8M | 34k | 51.80 | |
Vanda Pharmaceuticals (VNDA) | 1.0 | $1.5M | 88k | 16.85 | |
Encana Corp | 1.0 | $1.5M | 132k | 11.00 | |
Corcept Therapeutics Incorporated (CORT) | 0.8 | $1.2M | 76k | 16.45 | |
Soleno Therapeutics | 0.8 | $1.2M | 678k | 1.81 | |
Acceleron Pharma | 0.6 | $978k | 25k | 39.12 | |
Atara Biotherapeutics (ATRA) | 0.6 | $897k | 23k | 39.00 | |
G1 Therapeutics (GTHX) | 0.5 | $815k | 22k | 37.05 | |
Albireo Pharma | 0.5 | $782k | 24k | 32.58 | |
Masimo Corporation (MASI) | 0.5 | $704k | 8.0k | 88.00 | |
Axogen (AXGN) | 0.4 | $657k | 18k | 36.50 | |
Veracyte (VCYT) | 0.4 | $660k | 119k | 5.56 | |
Voyager Therapeutics (VYGR) | 0.4 | $620k | 33k | 18.79 | |
Sientra | 0.4 | $611k | 63k | 9.65 | |
Wright Medical | 0.4 | $595k | 30k | 19.83 | |
Clementia | 0.4 | $576k | 38k | 15.16 | |
Sito Mobile (STTO) | 0.4 | $563k | 140k | 4.02 | |
Biogen Idec (BIIB) | 0.4 | $548k | 2.0k | 274.00 | |
Biolase Technology | 0.3 | $527k | 1.3M | 0.41 | |
Yield10 Bioscience | 0.3 | $528k | 271k | 1.95 | |
Pioneer Natural Resources (PXD) | 0.3 | $515k | 3.0k | 171.67 | |
Amicus Therapeutics (FOLD) | 0.3 | $511k | 34k | 15.03 | |
Tesaro | 0.3 | $469k | 8.2k | 57.20 | |
Dicerna Pharmaceuticals | 0.3 | $430k | 45k | 9.56 | |
Shire | 0.3 | $403k | 2.7k | 149.26 | |
Arena Pharmaceuticals | 0.3 | $395k | 10k | 39.50 | |
Xencor (XNCR) | 0.2 | $369k | 12k | 30.00 | |
Oncomed Pharmaceuticals | 0.2 | $314k | 99k | 3.18 | |
Myriad Genetics (MYGN) | 0.2 | $296k | 10k | 29.60 | |
AVEO Pharmaceuticals | 0.2 | $290k | 100k | 2.90 | |
Ablynx Nv | 0.2 | $273k | 5.0k | 54.60 | |
Clovis Oncology | 0.2 | $264k | 5.0k | 52.80 | |
Intercept Pharmaceuticals In | 0.2 | $265k | 4.3k | 61.63 | |
Aevi Genomic | 0.2 | $257k | 128k | 2.01 | |
Genocea Biosciences | 0.1 | $199k | 189k | 1.05 | |
Quotient | 0.1 | $187k | 40k | 4.71 | |
Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.1 | $154k | 10k | 15.40 | |
Solid Biosciences | 0.1 | $150k | 20k | 7.50 | |
Workhorse Group Inc ordinary shares (WKHS) | 0.1 | $132k | 50k | 2.64 | |
Celgene Corp right 12/31/2011 | 0.1 | $70k | 242k | 0.29 | |
Cytokinetics (CYTK) | 0.1 | $72k | 10k | 7.20 |